MFT-6811 v1

Hatcher, A. E., Mendoza, S., & Hansen, H. (2018). At the expense of a life: Race, class, and the meaning of buprenorphine in pharmaceuticalized “care.” Substance Use & Misuse, 53(2), 301–310.
This article discusses the impact of using medication to treat opiate addiction and the inherent class differences in treatment availability.

May, E., Hunter, B., Ferrari, J., Noel, N., & Jason, L. (2015). Hope and abstinence self-efficacy: Positive predictors of negative affect in substance abuse recovery. Community Mental Health Journal, 51(6), 695–700.
This article addresses the racial differences in concepts which have been shown to be central to substance abuse recovery.

Kopak, A. M., Proctor, S. L., & Hoffmann, N. G. (2017). The cumulative risk associated with demographic background characteristics among substance use treatment patients. Addiction Research & Theory, 25(3), 216–224.
This article describes the impact of multiple demographic factors on substance abuse treatment outcomes.

Matsuzaka, S. (2018). Transgressing gender norms in addiction treatment: Transgender rights to access within gender-segregated facilities. Journal of Ethnicity in Substance Abuse, 17(4), 420–433.
This resource highlights the needs of transgender clients in addiction treatment.